CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (CAPITAL DEFICIENCY) - USD ($) $ in Thousands		Common Stock	Additional Paid-in Capital Adjustment	Additional Paid-in Capital	Accumulated Deficit Adjustment	Accumulated Deficit	Adjustment	Total
Beginning balance at Dec. 31, 2022		$ 54		$ 379,167		$ (389,861)		$ (10,640)
Beginning balance (in shares) at Dec. 31, 2022	[1]	53,790,167
Issuance of common stock under the Sales Agreement, net		$ 13		23,941				23,954
Issuance of common stock under the Sales Agreement, net (in shares)	[1]	12,560,150
Convertible notes conversions		$ 5		7,778				7,783
Convertible notes conversions (in shares)	[1]	4,691,623
Share-based compensation related to stock options				1,195				1,195
Share-based compensation related to restricted stock awards		$ 1		886				887
Share-based compensation related to restricted stock awards (in shares)	[1]	1,371,362
Exercise of warrants				712				712
Exercise of warrants (in shares)	[1]	538,822
Net income (loss) for the period						14,356		14,356
Ending balance at Sep. 30, 2023		$ 73		413,679		(375,505)		38,247
Ending balance (in shares) at Sep. 30, 2023	[1]	72,952,124
Beginning balance at Jun. 30, 2023		$ 72		412,582		(373,653)		39,001
Beginning balance (in shares) at Jun. 30, 2023	[1]	71,580,762
Share-based compensation related to stock options				383				383
Share-based compensation related to restricted stock awards		$ 1		714				715
Share-based compensation related to restricted stock awards (in shares)	[1]	1,371,362
Net income (loss) for the period						(1,852)		(1,852)
Ending balance at Sep. 30, 2023		$ 73		413,679		(375,505)		38,247
Ending balance (in shares) at Sep. 30, 2023	[1]	72,952,124
Beginning balance at Dec. 31, 2023		$ 73		415,045		(381,549)		33,569
Beginning balance (in shares) at Dec. 31, 2023	[1]	72,952,124
Share-based compensation related to stock options				1,191				1,191
Share-based compensation related to restricted stock awards		$ 1		1,407				1,408
Share-based compensation related to restricted stock awards (in shares)	[1]	681,459
Net income (loss) for the period						(3,562)		(3,562)
Ending balance (ASU 2020-06) at Sep. 30, 2024			$ (393)		$ 224		$ (169)
Ending balance at Sep. 30, 2024		$ 74		417,250		(384,887)		32,437
Ending balance (in shares) at Sep. 30, 2024	[1]	73,633,583
Beginning balance at Jun. 30, 2024		$ 73		416,631		(388,123)		28,581
Beginning balance (in shares) at Jun. 30, 2024	[1]	73,292,674
Share-based compensation related to stock options				358				358
Share-based compensation related to restricted stock awards		$ 1		261				262
Share-based compensation related to restricted stock awards (in shares)	[1]	340,909
Net income (loss) for the period						3,236		3,236
Ending balance (ASU 2020-06) at Sep. 30, 2024			$ (393)		$ 224		$ (169)
Ending balance at Sep. 30, 2024		$ 74		$ 417,250		$ (384,887)		$ 32,437
Ending balance (in shares) at Sep. 30, 2024	[1]	73,633,583

[1] Common stock, $0.001 par value; Authorized – as of September 30, 2024 and December 31, 2023 – 185,000,000 shares.